Surgical Robot Maker TransEnterix to Raise $50M in Stock Offering

Surgical Robot Maker TransEnterix to Raise $50M in Stock Offering Xconomy Raleigh-Durham — Wasting no time in preparing for commercialization of its surgical robot system, TransEnterix is pulling out plans to raise $50 million through a stock sale intended to finance sales and marketing of the technology.The plans come a week after Research Triangle Park, NC-based TransEnterix (NYSE: TRXC) applied to the FDA for regulatory clearance for its SurgiBot System.SurgiBot is a robotic system developed to enable surgeons to perform minimally invasive laparoscopic surgical procedures in the abdomen.In securities filings, TransEnterix says that traditional laparoscopy still requires multiple incisions for the surgeon to get the proper view and instrument positioning.The company also says that the rigid tools typically used force the surgeon’s arms and hands into awkward positions, making such procedures physically challenging.